Porcine-Derived Acellular Dermal Matrix for Buccal Soft Tissue Augmentation at Single Implant Sites: A 1-Year Follow-up Case Series

2020 ◽  
Vol 40 (1) ◽  
pp. 121-128 ◽  
Author(s):  
Martina Stefanini ◽  
Alexandra Rendon ◽  
Giovanni Zucchelli
Keyword(s):  
Soft Tissue ◽  
Case Series ◽  
Acellular Dermal Matrix ◽  
Soft Tissue Augmentation ◽  
Dermal Matrix ◽  
Tissue Augmentation ◽  
Acellular Dermal ◽  
Single Implant

scholarly journals Porcine Acellular Dermal Matrix: An Alternative to Connective Tissue Graft—A Narrative Review

2021 ◽  
Vol 2021 ◽  
pp. 1-7
Author(s):  
Shashi Dadlani
Keyword(s):  
Soft Tissue ◽  
Connective Tissue ◽  
Acellular Dermal Matrix ◽  
Soft Tissue Augmentation ◽  
Dermal Matrix ◽  
Connective Tissue Graft ◽  
Tissue Graft ◽  
Tissue Augmentation ◽  
Porcine Acellular Dermal Matrix ◽  
Acellular Dermal

Porcine acellular dermal matrix has recently been introduced in dentistry as an alternative to the gold standard connective tissue graft especially for the use in gingival recession treatments and soft tissue augmentation in implant surgery. Connective tissue grafts are inconvenient and require a second surgical site leading to greater morbidity, longer surgical procedures, and a more painful postoperative phase for the patient. Other options such as allografts have ethical concerns and are less available in Europe. Thus, dental professionals have sought other techniques and materials. Porcine acellular dermal matrix results in periodontal recession treatment with a gain in recession coverage as well as increased keratinized tissue and soft tissue augmentation. This leads to more keratinized mucosa and greater tissue thickness. Many studies have been published using collagen matrices, but a few strictly use porcine acellular dermal matrix, which have been studied in prospective randomized clinical trials with a large number of patients and longer follow-up periods (more than 5 years). Nevertheless, more data are needed to confirm that the porcine acellular dermal matrix is a suitable alternative although its favourable results to date suggest a positive future.

Threatened ventriculostomy shunt exposure: augmenting native soft tissue coverage with acellular dermal matrix graft

2012 ◽  
Vol 10 (4) ◽  
pp. 324-326
Author(s):  
Thomas Ridder ◽  
Shuhao Zhang ◽  
Gary Tye ◽  
Jennifer L. Rhodes
Keyword(s):  
Soft Tissue ◽  
Pediatric Population ◽  
Case Series ◽  
Acellular Dermal Matrix ◽  
Soft Tissue Augmentation ◽  
Shunt Revision ◽  
Soft Tissue Coverage ◽  
Dermal Matrix ◽  
History Of ◽  
Acellular Dermal

Avoiding threatened ventriculostomy shunt exposure in the pediatric population remains a difficult problem for the neurosurgeon and reconstructive surgeon. In this case series, the authors present a novel method of augmenting scalp soft tissue with acellular dermal matrix (ADM) in patients with a history of ventricular shunt revisions. Soft tissue augmentation with ADM successfully prevented shunt exposure in 3 patients with a history of shunt revision due to impending exposure following conventional techniques.

scholarly journals The Use of a Novel Porcine Derived Acellular Dermal Matrix (Mucoderm) in Peri-Implant Soft Tissue Augmentation: Preliminary Results of a Prospective Pilot Cohort Study

2018 ◽  
Vol 2018 ◽  
pp. 1-9 ◽  
Author(s):  
Piero Papi ◽  
Giorgio Pompa
Keyword(s):  
Soft Tissue ◽  
Acellular Dermal Matrix ◽  
Soft Tissue Augmentation ◽  
Outcome Variable ◽  
Postoperative Phase ◽  
Dermal Matrix ◽  
Tissue Augmentation ◽  
Keratinized Tissue ◽  
One Year ◽  
Acellular Dermal

Objective. Over the years, several techniques have been proposed for soft tissue augmentation around dental implants in order to improve keratinized mucosa width (KMW). Recently, a porcine derived acellular dermal matrix (Mucoderm®) has been proposed as autogenous graft substitute in order to avoid palatal harvesting and obtain comparable results to connective tissue grafts, in terms of aesthetics and function. The aim of this study is to present the one-year follow-up results of this matrix in peri-implant soft tissue augmentation procedures.Material and Methods. Twelve patients were enrolled in this pilot prospective study: a dental implant was placed in the upper premolar area and, at implant uncovering after eight weeks, the matrix was inserted. KMW gain was considered as primary outcome variable.Results. After one month from matrix insertion, mean KMW was 7.86±3.22 mm (100%), with no statistically significant intragroup variations (p>0.05). No membrane exposures or wound healing complications occurred during postoperative phase and, after one year, mean KMW was 5.67±2.12 mm (72.13%).Conclusions. The results of the present pilot study indicate that by placing a Mucoderm membrane during implant surgery the keratinized tissue width can be augmented, and the width remains stable for the assessment period of 12 months. Further studies with greater power and longer investigation period are needed to confirm the suggestion for clinical use. Clinical trial registration number is EudraCT number 2018-000147-16.

Sign in / Sign up

Export Citation Format

Share Document